New Horizon Health (FRA: 6YZ)

New Horizon Health is a corporation based in Hangzhou, China. Established in 2015, the company operates in the field of early cancer detection in China, with a focus on home-based testing. Its primary activities involve cancer screening and early diagnosis, and its main source of revenue is the ColoClear product. The assets are managed by the executive management team.